Presentations

A sense of urgency: evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies.

Cheng, S. K., Dietrich, M. S., & Dilts, D. M. (2010). A sense of urgency: evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies. Clinical Cancer Research, 16(22), 5557-5563.


admin

Predicting accrual achievement: monitoring accrual milestones of NCI-CTEP–sponsored clinical trials. Clinical Cancer Research,

Cheng, S. K., Dietrich, M. S., & Dilts, D. M. (2011). Predicting accrual achievement: monitoring accrual milestones of NCI-CTEP–sponsored clinical trials. Clinical Cancer Research, 17(7), 1947-1955.


admin

Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials. gov

Hirsch, B. R., Califf, R. M., Cheng, S. K., Tasneem, A., Horton, J., Chiswell, K., ... & Abernethy, A. P. (2013). Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials. gov. JAMA internal medicine, 173(11), 972-979.


admin

The importance of doing trials right while doing the right trials. Clinical Cancer Research,

Dilts, D. M., & Cheng, S. K. (2012). The importance of doing trials right while doing the right trials. Clinical Cancer Research, 18(1), 3-5.


admin

Building expertise in translational processes through partnerships with schools of business. In Translational Medicine-What, Why and How: An International Perspective

Cheng, S. K., & Dilts, D. M. (2012). Building expertise in translational processes through partnerships with schools of business. In Translational Medicine-What, Why and How: An International Perspective (Vol. 3, pp. 74-81). Karger Publishers.


admin

The Prevalence and Economic Impact of Low Enrolling Clinical Studies At An Academic Medical Center

Kitterman, D. R., Cheng, S. K., Dilts, D. M., & Orwoll, E. S. (2011). The prevalence and economic impact of low-enrolling clinical studies at an academic medical center. Academic medicine: journal of the Association of American Medical Colleges, 86(11), 1360.


admin

Phase III clinical trial development: a process of chutes and ladders. Clinical Cancer Research,

Dilts, D. M., Cheng, S. K., Crites, J. S., Sandler, A. B., & Doroshow, J. H. (2010). Phase III clinical trial development: a process of chutes and ladders. Clinical Cancer Research, 16(22), 5381-5389.


admin

Of Baseball, Medical Decision Making, and Innumeracy.

FERRANTI, L., CHENG, S., & DILTS, D. (2010). Of Baseball, Medical Decision Making, and Innumeracy. HANDBOOK OF DECISION MAKING, 501.


admin

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program.

Dilts, D. M., Sandler, A. B., Cheng, S. K., Crites, J. S., Ferranti, L. B., Wu, A. Y., ... & Abrams, J. (2009). Steps and time to process clinical trials at the Cancer Therapy Evaluation Program. Journal of Clinical Oncology, 27(11), 1761-1766.


admin

Development of clinical trials in a cooperative group setting: The Eastern Cooperative Oncology Group.

Dilts, D. M., Sandler, A., Cheng, S., Crites, J., Ferranti, L., Wu, A., ... & Comis, R. (2008). Development of clinical trials in a cooperative group setting: The Eastern Cooperative Oncology Group. Clinical Cancer Research, 14(11), 3427-3433.


admin

Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.

Dilts, D. M., Sandler, A. B., Baker, M., Cheng, S. K., George, S. L., Karas, K. S., ... & Scoggins, M. (2006). Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B. Journal of Clinical Oncology, 24(28), 4553-4557.


admin